These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38795093)

  • 21. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
    Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
    Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure (?) vs Anticoagulation Contraindication (!).
    Ruggiero R
    JACC Cardiovasc Interv; 2024 Aug; 17(15):1853. PubMed ID: 39142761
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry.
    Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Bansal A; Hsu JC; Freeman JV; Christen T; Allocco DJ; Gibson DN
    Circ Cardiovasc Interv; 2024 Sep; 17(9):e013750. PubMed ID: 39056187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reply: Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure (?) vs Anticoagulation Contraindication (!)?
    Aarnink EW; Maarse M; Boersma LVA
    JACC Cardiovasc Interv; 2024 Aug; 17(15):1854. PubMed ID: 39142762
    [No Abstract]   [Full Text] [Related]  

  • 25. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry.
    Cruz-González I; Ince H; Kische S; Schmitz T; Schmidt B; Gori T; Foley D; de Potter T; Tschishow W; Vireca E; Stein K; Boersma LV
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):21-27. PubMed ID: 30956034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
    Waranugraha Y; Lin LY; Tsai CT
    Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Labori F; Persson J; Bonander C; Jood K; Svensson M
    Eur Heart J; 2022 Mar; 43(13):1348-1356. PubMed ID: 34919652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding.
    Barocelli F; Coli S; Crocamo A; Guidorossi A; Cattabiani MA; Preti F; Bosi D; Spaziani C; Lina D; Menozzi A; Solinas E; Pelà G; Vignali L
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):583-591. PubMed ID: 32443136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
    Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
    Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
    Zeitler EP; Kearing S; Coylewright M; Nair D; Hsu JC; Darden D; O'Malley AJ; Russo AM; Al-Khatib SM
    Circulation; 2023 Feb; 147(7):586-596. PubMed ID: 36780379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation.
    Mohanty S; Mohanty P; Trivedi C; Assadourian J; Mayedo AQ; MacDonald B; Della Rocca DG; Gianni C; Horton R; Al-Ahmad A; Bassiouny M; Burkhardt JD; Di Biase L; Gurol ME; Natale A
    J Am Heart Assoc; 2021 May; 10(9):e019664. PubMed ID: 33870705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
    Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis.
    Ng AK; Ng PY; Ip A; Fung RC; Chui SF; Siu CW; Yan BP
    J Am Heart Assoc; 2023 Oct; 12(20):e029421. PubMed ID: 37804191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LAA occlusion is effective and safe in very high-risk atrial fibrillation patients with prior stroke: results from the multicentre German LAARGE registry.
    Ansari U; Brachmann J; Lewalter T; Zeymer U; Sievert H; Ledwoch J; Geist V; Hochadel M; Schneider S; Senges J; Akin I; Fastner C
    Clin Res Cardiol; 2024 Oct; 113(10):1451-1462. PubMed ID: 38294498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation.
    Maille B; Defaye P; Bentounes SA; Herbert J; Clerc JM; Pierre B; Torras O; Deharo JC; Fauchier L
    Mayo Clin Proc; 2024 May; 99(5):754-765. PubMed ID: 38180394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
    Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
    JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology.
    Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Stein KM; Bergmann MW
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):460-5. PubMed ID: 26719158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.